Anticancer Activity of Mycobacterial DNA: Effect of Formulation as Chitosan Nanoparticles

References

• Agrawal S., Zhao Q., Jiang Z., Oliver C., Giles H., Heath J., Serota D. Toxicologic effects of an oligodeoxyribonu-cleotide phosphorothioate and its analogs following intravenous administration in rats. Antisense Nucl. Acid Drug Dev. 1997; 7: 575–584
   PubMedGoogle Scholar
• Aspden T., Ilium L., Skaugrud O. Chitosan as delivery system: evaluation of insulin absorption enhancement and effect upon nasal membrane integrity using rat models. Eur. J. Pharm. Sci. 1996; 4: 23–31
   Web of Science ®Google Scholar
• Boussif O., Lezoualc'h F., Zanta M. A., Mergny M. D., Scherman B., Demeneix B., Behr J. P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleneimine. Proc. Natl. Acad. Sci. USA 1995; 92: 7297–7301
   PubMed Web of Science ®Google Scholar
• Calvo P., Remunan-Lopez C., Vila-Jato J. L., Alonso M. J. Chitosan and chitosan/ethylene oxyde propylene oxyde block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 1997; 14: 1431–1436
   PubMed Web of Science ®Google Scholar
• Chattoraj D. K., Gosule L. C., Schellman J. A. DNA condensation with polyamines. II. Elecron microscopic studies. Mol. Biol. 1978; 121: 327–337
   Web of Science ®Google Scholar
• Chonn A., Cullis PR. Recent advances in liposome technologies and their applications for systemic gene delivery. Adv. Drug Deliv. Rev. 1998; 30: 73–83
   PubMed Web of Science ®Google Scholar
• Crooke S. T. Therapeutic appplications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol. 1992; 32: 329–376
   PubMed Web of Science ®Google Scholar
• Erbacher P., Zou S., Bettinger T., Steffan A. M., Remy J. S. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm. Res. 1998; 15: 1332–1339
   PubMed Web of Science ®Google Scholar
• Felgner P. L., Gadek T. R., Holm M., Roman R., Chan H. S., Wenz J. P., Northrop M., Ringold M., Danielsen H. Lipofection: a highly efficient lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 1987; 84: 7413–7417
   PubMed Web of Science ®Google Scholar
• Filion M. C., Phillips N. C. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim. Biophys. Acta 1997; 1329: 345–356
   PubMed Web of Science ®Google Scholar
• Filion M. C., O'shea R., Collins J. K., Phillips N. C. Mycobacterial cell wall-DNA complex induces apoptosis in cancer cells. J. Pharm. Pharmacol. 1998; 50: 39
   Google Scholar
• Filion M. C., Filion B., Marie V., Reader S., Menard I., Phillips N. C. Mycobacterial cell wall-DNA complex (MCC) induces cycle arrest at the late S+G2M phase in leukemic cells. Br. J. Cancer 1999a; 80(Suppl. 2): 2–76
   Google Scholar
• Filion M. C., Lépicier P., Phillips N. C. Mycobacterium phlei cell wall complex directly induces apoptosis in human bladder cancer cells. Br. J. Cancer 1999b; 79: 229–235
   PubMed Web of Science ®Google Scholar
• Filion M. C., Filion B., Reader S., Menard S., Phillips N. C. Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex. Cancer Immunol, Immunother. 2000; 49: 325–334
   PubMed Web of Science ®Google Scholar
• Fisher P. L., Terhorst T., Cao X., Wagner R. W. Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucleic Acids Res. 1993; 21: 3857–3865
   PubMed Web of Science ®Google Scholar
• Haensler J., Szoka F.C., Jr. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chem. 1993; 4: 372–379
   PubMed Web of Science ®Google Scholar
• Halpern M. D., Kurlander R. J., Pisetsky D. S. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-oc. Cell immunol. 1996; 167: 72–78
   PubMed Web of Science ®Google Scholar
• Hoke G. D., Draper K., Freiser S. M., Gonzalez C., Driver V. B., Zounes M. C., Ecker D. J. Effects of phosphor-othioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucl. Acids Res. 1991; 19: 5743–5748
   PubMed Web of Science ®Google Scholar
• Huang L., Li S. Liposomal gene delivery: a complex package. Natl. Biotechnol. 1997; 15: 620–621
   PubMed Web of Science ®Google Scholar
• Iida R., Sawazaki K., Yasuda T., Tsubota E., Aoyawa M., Matsuk T., Kishi K. Deoxyribonuclease I phenotyping from saliva stains. J. Forensic Sci. 1999; 44: 175–178
   PubMed Web of Science ®Google Scholar
• Kabanov A. V. Taking polycation gene delivery systems from in vitro to. “in vivo”, Pharm. Sci. Technol. 1999; 2: 365–372
   PubMed Web of Science ®Google Scholar
• Kawabata K., Takakura Y., Hashida M. The fate of plasmid DNA after intravenous infection into mice: involvement of scavenger receptors in its hepatic uptake. Pharm. Res. 1995; 12: 825–830
   PubMed Web of Science ®Google Scholar
• Kijima H., Ishida H., Ohkawa T., Kashani-Sabet M., Scanlon K. J. Therapeutic application of ribozymes. Pharmacol. Ther. 1995; 68: 247–267
   PubMed Web of Science ®Google Scholar
• Klinman D. M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenecity of DNA vaccines. J. immunol. 1997; 158: 3635–3639
   PubMed Web of Science ®Google Scholar
• Krieg A., Yi A-K., Matson S., Waldschmidt T. J., Bishop G. A., Teasdale R., Koretzky G. A., Klinman D. M. CpG motifs in bacterial DNA triger direct B-cell activation. Nature 1995; 374: 546–549
   PubMed Web of Science ®Google Scholar
• Lew D., Parker S. E., Latimer T., Abai A. M., Kuwahara-Rundell A., Doh S. G., Yang Z. Y., Laface D., Gromokowski S. H., Nabel G. J. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Hum. Gene Ther. 1995; 6: 553–557
   PubMed Web of Science ®Google Scholar
• Leong K. W., Mao H. Q., Truong-Le V. L., Roy K., Walsh S. M., August J. T. DNA-polycation nanospheres as non viral gene delivery vehicles. J. Control. Release 1998; 53: 183–193
   PubMed Web of Science ®Google Scholar
• MacLaughlin F. C., Mumper R. J., Wang J., Tagliaferri J. M., Gill I., Hinchcliffe M., Rolland A. P. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Control. Release 1998; 56: 259–272
   PubMed Web of Science ®Google Scholar
• Maher L. J., Wold B., Dervan P. B. Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation. Science 1989; 245: 725–730
   PubMed Web of Science ®Google Scholar
• Mallick B. B., Kishore S., Das S. K., Garg A. Nonspecific immunostimulation against viruses. Comp. Immunol. Microbiol. Infect. Dis. 1985; 8: 55–63
   Web of Science ®Google Scholar
• Miller N., Vile R. Targeted vectors for gene therapy. FASEBJ. 1995; 9: 190–199
   PubMed Web of Science ®Google Scholar
• Moore D. D. Purification and concentration of DNA from aqueous solutions. Current Protocols in Molecular Biology, F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, K. Struhl. J. Wiley & Sons, Inc., New York 1998; 2.1.1–2.1.10
   Google Scholar
• Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 1983; 65: 55–63
   PubMed Web of Science ®Google Scholar
• Papapetropoulou M., Tsintzou A., Vantarakis A. Environmental mycobacteria in bottled table waters in Greece. Can. J. Microbiol. 1997; 43: 499–502
   PubMed Web of Science ®Google Scholar
• Patel H. M. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit. Rev. Ther. Drug Carrier Syst. 1992; 9: 39–90
   PubMed Web of Science ®Google Scholar
• Peluso G., Patella O., Rainiar M., Satin M., Ambrosia L., Celebre D., Avalon B., Balsam G. Chitosan mediated stimulation of macrophage function. Biomaterials 1994; 15: 1215–1220
   PubMed Web of Science ®Google Scholar
• Phillips N. C., Gagné L. Modulation of murine macrophage nitric oxide sythesis by liposomal phospholipid correlation with liposome immune adjuvant activity. J. Drug Target. 1995; 3: 137–147
   PubMed Web of Science ®Google Scholar
• Prince W. S., Baker D. L., Dodge A. H., Ahmed A. E., Chestnut R. W., Sinicropi D. V. Pharmacodynamics of recombinant human DNase I in serum. Clin. Exp. Immunol. 1998; 113: 289–296
   PubMed Web of Science ®Google Scholar
• Richardson S. C.W., Hanno V. J., Kolbe V. J., Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 1999; 178: 231–243
   PubMed Web of Science ®Google Scholar
• Robbins P. D., Tahara H., Ghivizzani S. C. Viral vectors for gene therapy. Trends Biotechnol. 1998; 16: 35–40
   PubMed Web of Science ®Google Scholar
• Roy K., Mao H. Q., Leong K. W. DNA chitosan nanospheres: transfection efficiency and cellular uptake. Proc. Int. Symp. Control. Rel. Bioact. Mater. 1997; 24: 673–674
   Google Scholar
• Sawayanagi Y., Nambu N., Nagai T. Use of chitosan for sustained-release preparations of water-soluble drugs. Chem. Pharm. Bull. 1982; 30: 4213–4215
   PubMed Web of Science ®Google Scholar
• Shimada S., Yano O., Inoue H., Kuramoto E., Fukuda T., Yamamoto H., Kataoka T., Tokunaga T. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. J. Natl. Cancer Inst. 1985; 74: 681–688
   PubMed Web of Science ®Google Scholar
• Stine K. C., Warren B. A., Becton D. L. Apoptosis induced by interleukin-12 measured by DNA electrophoresis and in situ end labelling in leukemia. Ann. N.Y. Acad. Sci. 1996; 795: 420–421
   PubMed Web of Science ®Google Scholar
• Tian X. X., Groves M. Formulation and biological activity of antineoplasic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles. J. Pharm. Pharmacol. 1999; 51: 151–157
   PubMed Web of Science ®Google Scholar
• Tokunaga T., Yamamoto H., Shimada S., Abe H., Fukuda T., Fujisawa Y., Furutani Y., Yano O., Kataoka T., Sudo T. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 1984; 72: 955–962
   PubMed Web of Science ®Google Scholar
• Tokunaga T., Yano O., Kuramoto E., Kimura Y., Yamamoto T, Kataoka T., Yamamoto S. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol. Immunol. 1992; 36: 55–66
   PubMed Web of Science ®Google Scholar
• Uhlmann E., Peyman A. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 1990; 90: 543–584
   Web of Science ®Google Scholar
• Vile R. G., Tuszynski A., Castleden S. Retroviral vectors: from laboratory tools to molecular medicine. Mol. Biotechnol. 1996; 5: 139–158
   PubMed Web of Science ®Google Scholar
• Wayne L. G., Gross W. M. Base composition of deoxyribonucleic acid isolated from mycobacteria. J. Bacterial. 1968; 96: 1915–1919
   PubMed Web of Science ®Google Scholar
• Wu G. Y., Wu C. H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 1987; 262: 4429–4932
   PubMed Web of Science ®Google Scholar
• Yamamoto S., Kuramoto E., Shimada S., Tokunaga T. In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn. J. Cancer Res. 1988; 79: 866–873
   PubMedGoogle Scholar
• Yei S., Mittereder N., Tang K., O'Sullivan C., Trapnell B. C. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1994; 1: 192–200
   PubMed Web of Science ®Google Scholar